Episode Details

In his weekly clinical update, Dr. Griffin reports the third case of influenza H5N1 infection in a human, this time with respiratory symptoms, an H5 avian influenza virus wastewater dashboard, FDA approves Moderna’s mRNA vaccine for respiratory syncytial virus, vaccine advisors to FDA recommend switching from the XBB.1.5 variant to JN.1 for fall COVID-19 vaccine formulations, weekly US COVID update, a controlled human exhaled breath aerosol experimental study on the relative efficacy of masks and respirators as source control for viral aerosol shedding from people infected with SARS-CoV-2, systematic review of early use of oral antiviral drugs and the risk of post COVID-19 syndrome, long-COVID autonomic syndrome in working age and work ability impairment, Centers for Disease Control and Prevention estimates that 5.3% of Americans currently have long COVID, and the National Academies of Sciences, Engineering, and Medicine presented a report with  a number of conclusions about long-COVID diagnosis, symptoms, and impact on daily function.

Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email

Become a patron of TWiV!

• More cattle and dairy workers infected with highly pathogenic H5N1 in Michigan (CDC Newsroom)
• Not eye but respiratory human H5N1 in Michigan (CIDRAP)
• Emory and Stanford’sH5N1 dashboard (Emory and Stanford)
• FDA approval for MRESVIA(FDA)
• Moderna RSV vaccine for the elderly (CIDRAP)
• Moderna announces approval of MRESVIA (moderna)
• FDA VRBPAC meeting for fall COVID boosters (FDA)
• JN.1 variant for fall booster (CIDRAP)
• COVID-19 national trend (CDC)
• COVID-19 deaths (CDC)
• Masks and respirators for source control from viral aerosol shedding (Lancet)
• Spring vaccine advice (CIDRAP)
• Older adult spring booster available (CDC)
• Advisory committee for immunization practices slide